Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDCO

Medicines (MDCO) Stock Price, News & Analysis

Medicines logo

About Medicines Stock (NASDAQ:MDCO)

Key Stats

Today's Range
$84.90
$84.90
50-Day Range
$84.90
$84.90
52-Week Range
$17.81
$84.98
Volume
N/A
Average Volume
9.55 million shs
Market Capitalization
$6.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicines and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDCO Stock News Headlines

IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
BeOne Medicines Completes Employee Share Purchase Plan
See More Headlines

MDCO Stock Analysis - Frequently Asked Questions

The Medicines Company (NASDAQ:MDCO) issued its quarterly earnings results on Wednesday, October, 30th. The company reported ($0.92) EPS for the quarter, missing the consensus estimate of ($0.80) by $0.12.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicines investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Gilead Sciences (GILD), Micron Technology (MU), AbbVie (ABBV), Alibaba Group (BABA) and Salesforce (CRM).

Company Calendar

Last Earnings
10/30/2019
Today
9/23/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:MDCO
CIK
1113481
Fax
N/A
Employees
62
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.91)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$123.16 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-25.70%

Debt

Debt-to-Equity Ratio
21.45
Current Ratio
0.77
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$6.14 million
Price / Sales
1,102.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.30) per share
Price / Book
-283.00

Miscellaneous

Outstanding Shares
79,723,000
Free Float
N/A
Market Cap
$6.77 billion
Optionable
Optionable
Beta
1.10
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:MDCO) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners